Serina Therapeutics, Inc. Quarterly Depreciation in USD from Q1 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Serina Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from Q1 2018 to Q2 2024.
  • Serina Therapeutics, Inc. Depreciation for the quarter ending June 30, 2024 was $24K, a 33.3% increase year-over-year.
  • Serina Therapeutics, Inc. annual Depreciation for 2020 was $699K, a 668% increase from 2019.
  • Serina Therapeutics, Inc. annual Depreciation for 2019 was $91K, a 56.9% increase from 2018.
  • Serina Therapeutics, Inc. annual Depreciation for 2018 was $58K, a 64.8% decline from 2017.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $24K +$6K +33.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 $23K +$10K +76.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q2 2023 $18K Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 $13K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q1 2020 $204K $123K +$113K +1130% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 $91K -$48K -$58K -580% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-31
Q3 2019 $149K $117K +$94K +409% Jul 1, 2019 Sep 30, 2019 10-Q 2019-11-14
Q2 2019 $55K $12K +$2K +20% Apr 1, 2019 Jun 30, 2019 10-Q 2019-08-14
Q1 2019 $53K $10K -$5K -33.3% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q4 2018 $58K $10K Oct 1, 2018 Dec 31, 2018 10-K/A 2020-03-31
Q3 2018 $23K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 $10K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 $15K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.